Adenocarcinoma and Urachal Lithiasis, Review of the Literature and Report of a Case
DOI:
https://doi.org/10.54212/27068048.v11i1.144Keywords:
Urachal adenocarcinoma, Cystoscopy, Partial cystectomyAbstract
Aims: Present a clinical case of a patient with urachal adenocarcinoma and urachal lithiasis, who underwent diagnostic cystoscopy and partial cystectomy as well as a review of the literature. Background: Urachal adenocarcinoma is a tumor with a rare incidence, which is diagnosed late, therefore it can have a poor prognosis, and in many cases local recurrences and metastases occur within 2 years after diagnosis. Clinical case: A 61-year-old female patient with symptoms of hematuria of 10 days of evolution, associated with pain in the suprapubic region of mild/moderate intensity. She refers that she has had recurrent urinary tract infections, for which it was decided to perform a urotomography, evidencing persistence of the urachus in the tertiary care hospital (Roosevelt Hospital). Diagnostic cystoscopy was performed confirming the presence of urachus and intravesical stones. A partial cystectomy was subsequently performed, and the biopsy reported moderately differentiated urachal adenocarcinoma. The patient is discharged, leaving control appointments for external consultation. Conclusions: Partial cystectomy and resection of the urachal remnant is the ideal treatment. This type of surgery has benefits by decreasing morbidity, preserving the perivesical nerves, and preserving the normal function of the urinary tract. Generally, partial cystectomy is indicated in patients who present a solitary tumor in the bladder dome and lesions on the lateral side of the bladder that do not affect the ureteral tract. It is important to have constant monitoring of patients through diagnostic cystoscopies due to the risk that there may be recurrences or metastases.
Downloads
References
Zamora, G. Elizabeth, & O'Brien S, Andrés. (2006). URACO: ANOMALIAS DEL DESARROLLO, CARACTERISTICAS ANATOMICAS Y PRESENTACION DE DOS CASOS. Revista chilena de radiología, 12(1), 9-11. https://doi.org/10.4067/S0717-93082006000100004
García Salazar, Natalia, Pérez Silva, Margarita María, & Acuña Hernández, Marylin. (2018). Carcinoma de uraco, una neoplasia maligna poco frecuente. Revista Médica del Uruguay, 34(1), 124-133. https://doi.org/10.29193/RMU.34.1.6
Gopalan, Anuradha MD*; Sharp, David S. MD†; Fine, Samson W. MD*; Tickoo, Satish K. MD*; Herr, Harry W. MD†; Reuter, Victor E. MD*; Olgac, Semra MD*. Urachal Carcinoma: A Clinicopathologic Analysis of 24 Cases With Outcome Correlation. The American Journal of Surgical Pathology 33(5):p 659-668, May 2009. https://doi.org/10.1097/PAS.0b013e31819aa4ae
Martín Hernández, Diana, Prieto Matos, Pablo, Díez Hernández, Juan Carlos, Liras Muñoz, Jorge, & Celis Villasana, Luis de. (2009). Persistencia de uraco infectado como causa de abdomen agudo: A propósito de un caso. Archivos Españoles de Urología (Ed. impresa), 62(7), 589-592. Recuperado en 3 de mayo de 2023, de https://doi.org/10.4321/S0004-06142009000700010
Donate Moreno, M.J., Giménez Bachs, J.M., Salinas Sánchez, A.S., Lorenzo Romero, J.G., Segura Martín, M., Hernández Millán, I., Pastor Guzmán, J.Mª, Ruiz Mondéjar, R., & Virseda Rodríguez, J.. (2005). Patología del uraco: revisión de conjunto y presentación de tres casos. Actas Urológicas Españolas, 29(3), 332-336. Recuperado en 3 de mayo de 2023, de https://doi.org/10.1016/S0210-4806(05)73249-6
Donat SM, Herr HW. Urachal tumors. In: NJ Vogelzang, PT Scardino, WU Shipley, FMJ DeBruyne,WM Linehan, editors. Comprehensive Textbook of Genitourinary Oncology. 3rd ed. Vol 1.Philadelphia: Lippincott Williams and Wilkins; 2005: 893- 897.
J.N. Eble, G. Sauter, J.I. Epstein, I.A. Sesterhenn. World Health Organization classification of tumours: Pathology and genetics of head and neck tumours. IARC Press, 85 (2006), pp. 128-132.
Sheldon CA, Clayman RV, Gonzalez R, Williams RD, Fraley EE. Malignant urachal lesions. J Urol.1984; 131: 1- 8. https://doi.org/10.1016/S0022-5347(17)50167-6
Gómez Rebollo, Celestino, Márquez Moreno, Antonio Javier, Antuña Calle, Francisco, Pérez Villa, Lidia, Sánchez Carrillo, Juan José, Julve Villalta, Emilio, Blanes Berenguel, Alfredo, & Acebal Blanco, Mercedes. (2010). Adenocarcinoma de uraco con metástasis cerebrales tardías. Archivos Españoles de Urología (Ed. impresa), 63(7), 550-554. Recuperado en 17 de mayo de 2023, de https://doi.org/10.4321/S0004-06142010000700012
Siefker-Radtke AO, Gee J, Shen Y, et al. Multimodality management of urachal carcinoma: the M. D. Anderson Cancer Center experience. J Urol. 2003; 169: 1295- 1298. https://doi.org/10.1097/01.ju.0000054646.49381.01
Besarani D, Purdie CA, Townell NHRecurrent urachal adenocarcinomaJournal of Clinical Pathology 2003;56:882. https://doi.org/10.1136/jcp.56.11.882
16. Reyes-Arroyo Jorge, Mejía-Ríos Laura C., Fernández-Vivar Elieser, Gutiérrez-Quiroz Claudia T., Priego-Niño Alejandro, Montiel-Jarquín Álvaro J.. Adenocarcinoma de uraco. Análisis de 8 años en un centro hospitalario de tercer nivel de atención. Cir. cir. [revista en la Internet]. 2021 Feb [citado 2023 Jun 21] ; 89( 1 ): 71-76. Disponible en: Epub 08-Nov-2021. https://doi.org/10.24875/CIRU.19001597
Siefker-Radtke AO, Gee J, Shen Y, et al. Multimodality management of urachal carcinoma: the M. D. Anderson Cancer Center experience. J Urol. 2003; 169: 1295- 1298. https://doi.org/10.1097/01.ju.0000054646.49381.01
Reis H, Krafft U, Niedworok C, Módos O, Herold T, Behrendt M, Al-Ahmadie H, et al. Biomarkers in Urachal Cancer and Adenocarcinomas in the Bladder:A Comprehensive Review Supplemented by Own Data. Dis Markers. 2018;2018:7308168. https://doi.org/10.1155/2018/7308168
P. Cruz, M. Ramírez, I. Iborra, J. Rubio, F. Pinto, A. Gómez-Ferrer, A. Collado, J.L. Domínguez, J. Casanova, J.V. Ricós, J.L. Monrós, E. Solsona (2014). Adenocarcinoma de uraco: ¿qué tanto sabemos? Revista Mexicana de Urología Vol. 74. Núm. 5. (301-307), Sep-Oct 2014. https://doi.org/10.1016/j.uromx.2014.09.002
Güral, Zeynep; Yücel, Serap; Oskeroğlu, Sedenay1; Ağaoğlu, Fulya. Urachal adenocarcinoma: A case report and review of the literature. Journal of Cancer Research and Therapeutics 18(1):p 291-293, Jan-Mar 2022. https://doi.org/10.4103/jcrt.JCRT_28_20
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Víctor Alfonso Lee Del Cid, Ángel David Valdez Vargas y Marco Antonio Ortiz Herrera
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License 4.0 that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.